Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis

PURPOSE: Although oral prednisolone is the first-line treatment for preventing recurrent optic neuritis (ON) after the completion of acute-phase treatment, especially anti-aquaporin 4 (AQP4) antibody-positive ON, and anti-myelin oligodendrocyte glycoprotein (MOG) antibody-positive ON, some patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Ophthalmol
Main Authors: Mori, Sotaro, Kurimoto, Takuji, Murai, Yusuke, Ueda, Kaori, Sakamoto, Mari, Chihara, Norio, Yamada-Nakanishi, Yuko, Nakamura, Makoto
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7883711/
https://ncbi.nlm.nih.gov/pubmed/33628473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8871146
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados